Page last updated: 2024-12-08
corollosporine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
corollosporine: isolated from marine fungus Corollospora maritima; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 154159 |
| MeSH ID | M0295831 |
Synonyms (7)
| Synonym |
|---|
| 3-hexyl-3,7-dihydroxy-1(3h)-isobenzofuranone |
| 3-hexyl-3,7-dihydroxy-2-benzofuran-1-one |
| 1(3h)-isobenzofuranone, 3-hexyl-3,7-dihydroxy- |
| 211441-46-2 |
| corollosporine |
| 3-hexyl-3,7-dihydroxy-2-benzofuran-1(3h)-one |
| DTXSID80943466 |
Research Excerpts
Overview
Corollosporine is an antimicrobial metabolite. It was isolated from the marine fungus Corollospora maritima.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Corollosporine is an antimicrobial metabolite, which was isolated from the marine fungus Corollospora maritima. " | ( Synthesis and antimicrobial activity of N-analogous corollosporines. Beller, M; Hübner, S; Klaus, S; Lalk, M; Lindequist, U; Neumann, H; Spannenberg, A; Strübing, D, 2006) | 2.03 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.03
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.03) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||